Leap Therapeutics
LPTX
$2.43
Share price
2.97%
Change (1 day)
161.29%
Change (1 year)
Categories
Operating Margin for Leap Therapeutics (LPTX)
Operating Margin as of June 2024 (TTM): -2,707.40%
According to Leap Therapeutics 's latest financial reports and stock price the company's current Operating Margin is -2,707.40%. At the end of 2021 the company had an Operating Margin of -2,707.40%.
Operating Margin history for Leap Therapeutics from 2020 to 2021
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -2,707.40% | 47.59% |
| 2020 | -1,834.40% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.